🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 5 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/12/2021 85,46 87,64 84,74 85,49 +0,04% 3,39% 422.000
09/12/2021 88,41 89,70 85,29 85,46 -0,65% 4,99% 671.500
08/12/2021 86,00 88,20 84,87 86,02 +0,81% 3,87% 1.349.800
07/12/2021 82,26 85,89 82,03 85,33 +4,44% 4,69% 1.068.300
06/12/2021 77,71 82,27 76,71 81,70 +4,08% 7,15% 818.700
03/12/2021 83,39 83,39 76,23 78,50 -5,64% 8,59% 1.722.200
02/12/2021 82,10 85,25 81,72 83,19 +1,22% 4,30% 734.200
01/12/2021 80,66 85,28 80,25 82,19 +1,71% 6,24% 852.600
30/11/2021 79,35 80,91 77,69 80,81 +1,19% 4,06% 1.001.700
29/11/2021 81,54 81,83 79,76 79,86 +0,30% 2,54% 602.700
26/11/2021 80,56 81,44 78,68 79,62 -1,68% 3,43% 473.500
24/11/2021 79,87 81,51 78,04 80,98 +2,08% 4,34% 415.300
23/11/2021 78,13 79,65 75,80 79,33 +1,26% 4,93% 782.100
22/11/2021 81,14 81,14 78,26 78,34 -2,09% 3,55% 1.484.800
19/11/2021 80,21 81,08 79,36 80,01 -1,11% 2,14% 835.800
18/11/2021 81,78 82,98 80,52 80,91 +1,49% 3,01% 1.021.700
17/11/2021 82,00 82,80 79,05 79,72 -3,95% 4,57% 1.229.800
16/11/2021 83,53 84,44 82,47 83,00 -1,05% 2,36% 599.200
15/11/2021 85,50 85,88 83,81 83,88 -1,25% 2,42% 497.400
12/11/2021 85,96 87,15 84,31 84,94 -1,35% 3,30% 681.900
11/11/2021 86,27 86,80 85,56 86,10 -0,02% 1,44% 390.700
10/11/2021 87,55 88,48 85,57 86,12 -2,06% 3,32% 652.300
09/11/2021 89,14 90,30 86,75 87,93 -1,39% 3,98% 600.300
08/11/2021 88,95 90,57 87,66 89,17 +0,27% 3,27% 1.631.900
05/11/2021 91,56 91,90 87,91 88,93 +2,25% 4,36% 1.219.500
04/11/2021 90,68 92,50 86,40 86,97 +0,51% 6,73% 1.488.800
03/11/2021 81,95 86,55 81,03 86,53 +6,13% 6,74% 1.559.800
02/11/2021 80,00 81,67 78,88 81,53 +1,84% 3,49% 1.063.900
01/11/2021 79,25 81,92 78,91 80,06 +1,18% 3,80% 1.015.700
29/10/2021 79,29 79,89 77,62 79,13 -0,15% 2,86% 1.035.800